Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate capsules and other antibacterial drugs, doxycycline hyclate capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae . - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophil a   psittaci . - trachoma caus

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae . - respiratory tract infections caused by mycoplasma pneumoniae . - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

qpharma inc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae . - respiratory tract infections caused by mycoplasma pneumoniae . - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydophila psittaci . -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - doxycycline (unii: n12000u13o) (doxycycline anhydrous - unii:334895s862) - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules, usp and other antibacterial drugs, doxycycline capsules, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline capsules, usp are indicated for the treatment of the following infections: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae . lymphogranuloma venereum caused by chlamydia trachomatis . psittacosis (ornithosis) caused by chlamydophila psittaci . trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia trachomatis . uncomplicated urethral, endocervical or rectal infections in adults caused by chlamydia trachomatis . nongonococcal urethritis caused by ureaplasma urealyticum . relapsing fever due to borrelia recurrentis . doxycycline capsules, usp are also indicated for the treatment of infections caused by the following gram-negative microorganisms: chancroid caused by haemophilus ducreyi . plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infections caused by campylobacter fetus . brucellosis due to brucella species (in conjunction with streptomycin). bartonellosis due to bartonella bacilliformis . granuloma inguinale caused by klebsiella granulomatis. because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug: escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae . respiratory tract and urinary tract infections caused by klebsiella species . doxycycline capsules, usp are indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: upper respiratory infections caused by streptococcus pneumoniae . anthrax due to bacillus anthracis , including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis . when penicillin is contraindicated, doxycycline capsules, usp are an alternative drug in the treatment of the following infections: uncomplicated gonorrhea caused by neisseria gonorrhoeae . syphilis caused by treponema pallidum . yaws caused by treponema pallidum subspecies pertenue listeriosis due to listeria monocytogenes . vincent’s infection caused by fusobacterium fusiforme . actinomycosis caused by actinomyces israelii . infections caused by clostridium species . in acute intestinal amebiasis, doxycycline capsules, usp may be a useful adjunct to amebicides. in severe acne, doxycycline capsules, usp may be useful adjunctive therapy. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Poola - poola - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

synoptis pharma sp. z o.o. - doxycyclini hyclas - kapsułki twarde - 100 mg

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aliud pharma gmbh (3270510) - doxycyclin-monohydrat - hartkapsel - teil 1 - hartkapsel; doxycyclin-monohydrat (19716) 208,2 milligramm

Saksamaa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aliud pharma gmbh (3270510) - doxycyclinhyclat - tablette - teil 1 - tablette; doxycyclinhyclat (03877) 230,8 milligramm

Prantsusmaa - prantsuse - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoires bailleul sa - doxycycline anhydre 100 - comprimé - 100,00 mg - pour un comprimé > doxycycline anhydre 100,00 mg sous forme de : doxycycline monohydratée 104,10 mg - antibacteriens a usage systemique - classe pharmacothérapeutique - code atc : j01aa02la doxycycline est un antibiotique de la famille des tétracyclines.ce médicament est indiqué dans le traitement des infections à germes sensibles à la doxycycline dans leurs manifestations respiratoires, génitales, urinaires, cutanées, oculaires ou générales.votre médecin peut aussi vous le prescrire dans le traitement de certaines formes d'acné, ainsi que dans la rosacée dans ses manifestations cutanées ou oculaires.

Prantsusmaa - prantsuse - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoires bailleul sa - doxycycline anhydre 50 - comprimé - 50,00 mg - pour un comprimé > doxycycline anhydre 50,00 mg sous forme de : doxycycline monohydratée 52,05 mg - antibacteriens a usage systemique - classe pharmacothérapeutique - code atc : j01aa02la doxycycline est un antibiotique de la famille des tétracyclines.ce médicament est indiqué dans le traitement des infections à germes sensibles à la doxycycline dans leurs manifestations respiratoires, génitales, urinaires, cutanées, oculaires ou générales.votre médecin peut aussi vous le prescrire dans le traitement de certaines formes d'acné, ainsi que dans la rosacée dans ses manifestations cutanées ou oculaires.

Belgia - prantsuse - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - doxycycline monohydraté 104,1 mg - comprimé - 100 mg - doxycycline 104.1 mg - doxycycline